<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00603096</url>
  </required_header>
  <id_info>
    <org_study_id>38/2006/2</org_study_id>
    <secondary_id>Ethics Comittee ref.06-TYCO-1</secondary_id>
    <nct_id>NCT00603096</nct_id>
  </id_info>
  <brief_title>Use of Polysomnography for Non-Invasive Ventilation Settings' Optimization</brief_title>
  <acronym>NIV-OHS</acronym>
  <official_title>Interest of Using Nocturnal Polysomnography for Non-Invasive Ventilation (NIV) Settings' Optimization in Obesity-Hypoventilation Syndrome (OHS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tyco Healthcare Group</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tyco Healthcare Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this randomized controlled trial is comparing the improvement of diurnal PaCO2 in&#xD;
      OHS patients after one month of NIV treatment depending upon the tools used for adjusting&#xD;
      settings. In one arm settings will be adjusted using only nocturnal oxygen SaO2 and PaCO2 at&#xD;
      awakening whereas in the other arm patients will benefit from a complete polysomnography&#xD;
      under NIV.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Initiation of NIV treatment implies technical adjustments (choice of mask and ventilator),&#xD;
      but also patient education by the nurses and medical staff. The settings are generally&#xD;
      adjusted during the daytime in awake patients. The appropriateness of these settings is&#xD;
      generally not optimal during sleep as many respiratory events (hypopnoea, apnea, leaks,&#xD;
      desynchronization, and glottic closure) may occur under NIV then reducing the effectiveness&#xD;
      of treatment. These nocturnal abnormalities are routinely evaluated by measuring their&#xD;
      consequences, i.e. oxygen desaturation and the level of PaCO2 after wake up. Some teams are&#xD;
      now proposing to better characterize what happens when using NIV during sleep using&#xD;
      polysomnography (PSG). The precise characterization of residual events under treatment may&#xD;
      allow optimizing ventilator settings.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2006</start_date>
  <completion_date type="Anticipated">June 2008</completion_date>
  <primary_completion_date type="Anticipated">June 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diurnal PaCO2</measure>
    <time_frame>June 2008</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Obesity-Hypoventilation Syndrome (OHS)</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will benefit from a complete polysomnography under NIV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>settings will be adjusted using only nocturnal oxygen SaO2 and PaCO2 at awakening whereas</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GoodKnight 425ST - Mallinckrodt DF, Tyco Healthcare</intervention_name>
    <description>The aim of this randomized controlled trial is comparing the improvement of diurnal PaCO2 in OHS patients after one month of NIV treatment depending upon the tools used for adjusting settings. In one arm settings will be adjusted using only nocturnal oxygen SaO2 and PaCO2 at awakening whereas in the other arm patients will benefit from a complete polysomnography under NIV.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient male or female, aged 20 to 75 years&#xD;
&#xD;
          -  Patient with a OHS in stable condition, with a BMI&gt; 32 kg/m2 and a PaCO2&gt; 6 kPa in&#xD;
             diurnal spontaneous breathing without other cause of alveolar hypoventilation&#xD;
&#xD;
          -  Patient affiliated to a social security insurance&#xD;
&#xD;
          -  Having given its written informed consent to participate to the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with inherent chronic obstructive pulmonary disease (COPD) with FEV1 on&#xD;
             Forced Vital Capacity (FVC) ratio less than 70%&#xD;
&#xD;
          -  Patients suffering from heart failure with periodic breathing&#xD;
&#xD;
          -  Associated Neurological Diseases, evolving rapidly, leading to a dependency in daily&#xD;
             activities&#xD;
&#xD;
          -  Unbalanced Psychiatric Diseases&#xD;
&#xD;
          -  Patients with a respiratory decompensation the month preceding the study&#xD;
&#xD;
          -  Patients not autonomous in the use of the NIV&#xD;
&#xD;
          -  Pacemaker patients, constituting a contraindication to magnetic stimulation&#xD;
&#xD;
          -  Sensitive subjects, in accordance with article L 1121-6 of the French Public Health&#xD;
             Code&#xD;
&#xD;
          -  Patients with long term by steroids or other anti-inflammatory drugs&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Louis pepin, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maud Boucherie, CRA</last_name>
    <email>maud.boucherie@covidien.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Laboratoire d'Explorations Fonctionnelles Cardio-Respiratoires - CHU Grenoble</name>
      <address>
        <city>Grenoble</city>
        <state>Cedex 9</state>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Louis Pepin, Pr</last_name>
      <email>JLPepin@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>Jean-Christian Borel</last_name>
      <email>JCBorel@chu-grenoble.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2008</verification_date>
  <study_first_submitted>January 15, 2008</study_first_submitted>
  <study_first_submitted_qc>January 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2008</study_first_posted>
  <last_update_submitted>January 15, 2008</last_update_submitted>
  <last_update_submitted_qc>January 15, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2008</last_update_posted>
  <responsible_party>
    <name_title>EMEA Clinical Affairs Director</name_title>
    <organization>tyco Healthcare Group</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoventilation</mesh_term>
    <mesh_term>Obesity Hypoventilation Syndrome</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

